Grufity logoGrufity logo

SWAV

249.74USD-7.53(-2.93%)Market Closed

Shockwave Medical Inc

Market Summary

USD249.74-7.53Market Closed
-2.93%

SWAV Alerts

SWAV Stock Price

RSI Chart

Valuation

Market Cap

10.2T

Price/Earnings

185.5K

Price/Sales

28.0K

Price/Cashflow

167.3K

MarketCap/EBT

181.7K

Price/Sales

Profitability

EBT Margin

15.43%

Return on Equity

18.02%

Return on Assets

13.18%

Fundamentals

Revenue

Revenue (TTM)

429.9M

Revenue Y/Y

101.57%

Revenue Q/Q

8.77%

Earnings

Earnings (TTM)

88.0M

Earnings Y/Y

1.7K%

Earnings Q/Q

36.94%

Price Action

52 Week Range

320.54
(Low)(High)

Last 7 days

-1.0%

Last 30 days

-12.3%

Last 90 days

-15.9%

Trailing 12 Months

37.4%

Financial Health

Current Ratio

5.32

Debt/Equity

0.06

Debt/Cashflow

3.5

Investor Care

Shares Dilution (1Y)

2.27%

Diluted EPS (TTM)

391.97

Peers (Alternatives to Shockwave Medical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
SWAV
10.2T
429.9M
 -12.27% 37.42%
185.5K
28.0K
 144.70% 331.94%
SYK
86.7B
17.9B
 -0.89% -5.88%
41.71
4.92
 7.67% 29.32%
ISRG
86.3B
6.1B
 6.00% -22.69%
62.6
14.1
 11.47% -18.42%
BDX
67.1B
18.9B
 2.45% 2.44%
38.21
3.25
 -6.81% -14.96%
BSX
61.8B
12.3B
 3.10% 15.31%
69.9
5.01
 10.11% 51.89%
EW
43.9B
5.4B
 5.62% -32.39%
30.09
8.18
 5.29% -1.25%
MID-CAP
GMED
6.7B
998.4M
 6.78% 12.55%
44.21
6.87
 6.04% -19.01%
PEN
6.4B
806.4M
 17.87% -18.76%
-331.15
7.96
 20.10% -221.96%
IRTC
3.9B
380.1M
 -19.31% 2.07%
-29.57
10.69
 18.85% -63.58%
TNDM
3.6B
790.7M
 -28.81% -69.43%
-273.58
4.7
 19.65% -412.22%
SMALL-CAP
SILK
1.6B
126.8M
 14.47% 24.81%
-26.38
14.01
 34.44% -10.05%
ATEC
1.1B
291.9M
 -4.68% -9.70%
-6.57
3.67
 52.45% -57.74%
AVNS
1.0B
795.9M
 17.65% -15.21%
-131.34
1.33
 8.11% 182.50%
CSII
606.7M
236.2M
 -9.66% -36.62%
-16.43
2.57
 -8.79% -175.19%

Financials for Shockwave Medical

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue18.2%430364299237176
Gross Profit19.1%370310252196140
  S&GA Expenses9.9%15213812311195
  R&D Expenses9.7%7366575145
Earnings Before Taxes59.0%895629-8.84-37.75
Net Income60.1%885529-9.14-37.95
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets14.1%476417373346299
  Current Assets12.3%395352310286256
    Cash Equivalents27.9%128100668991
  Inventory14.9%6960534339
  Net PPE21.7%3932282423
Liabilities7.0%12011210510479
  Current Liabilities-18.1%5466515240
  Long Term Debt-14.8%1517171717
    LT Debt, Current-100.0%-11863
    LT Debt, Non Current130.6%15691214
Shareholder's Equity16.7%356305268242220
  Retained Earnings16.5%-177.72-212.73-238.29-252.81-265.80
  Additional Paid-In Capital3.1%535519507495486
Accumulated Depreciation-6----
Shares Outstanding0.7%35,82635,587---
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations41.3%86613415-18.19
  Share Based Compensation12.0%4036322722
Cashflow From Investing-1.0%-49.98-49.48-28.0826-104.09
Cashflow From Financing-33.9%463-2.45-1.78

Risks

What is the probability of a big loss on SWAV?

98.0%

Probability that Shockwave Medical stock will be more than 20% underwater in next one year

68.9%

Probability that Shockwave Medical stock will be more than 30% underwater in next one year.

61.2%

Probability that Shockwave Medical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does SWAV drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Shockwave Medical was unfortunately bought at previous high price.

Returns

Cumulative Returns on SWAV

85.5%

3-Year Cumulative Returns

Which funds bought or sold SWAV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Toroso Investments, LLC
ADDED
4.82
209,000
605,000
 0.03%
2022-11-22
Capital Impact Advisors, LLC
-
-
188,000
1,077,000
 1.07%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
1,690,000
1,690,000
 0.02%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
3,746,000
12,480,000
 0.02%
2022-11-21
Parallax Volatility Advisers, L.P.
NEW
-
15,000
15,000
 -%
2022-11-17
CENTRAL TRUST Co
ADDED
37,300
208,000
208,000
 0.01%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-253,000
-
 -%
2022-11-16
GLENMEDE TRUST CO NA
REDUCED
-64.26
-481,000
519,000
 -%
2022-11-16
Verity Asset Management, Inc.
NEW
-
279,460
279,460
 0.29%
2022-11-16
Retirement Systems of Alabama
REDUCED
-0.24
4,065,000
13,079,000
 0.06%

1–10 of 45

Latest Funds Activity

Are funds buying SWAV calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own SWAV

SWAV Alerts

Shockwave Medical News

MarketBeat

ShockWave Medical (NASDAQ:SWAV) Trading Down 3% on Insider Selling.17 hours ago

Nasdaq

Here's Why You Should Hold OPKO Health (OPK) Stock For Now.17 hours ago

Nasdaq

Merit Medical (MMSI) Launches New Inflation Device basixALPHA.18 hours ago

Nasdaq

Factors That Make Elevance Health (ELV) a Lucrative Bet Now.36 hours ago

Nasdaq

AmerisourceBergen (ABC) Hits 52-Week High: What's Driving It?.39 hours ago

Nasdaq

Boston Scientific (BSX) Posts Positive Post-Market Study Data.39 hours ago

Nasdaq

QIAGEN's (QGEN) New Monkeypox Test to Aid Faster Identification.4 days ago

Nasdaq

Here's Why You Should Retain Stryker (SYK) Stock For Now.4 days ago

Investor's Business Daily

Futures: 5 Stocks Near Buys; Tesla FSD Beta Expands Widely.4 days ago

Nasdaq

Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio.5 days ago

Nasdaq

Here's Why You Should Retain Cardinal Health (CAH) Stock Now.5 days ago

InvestorPlace

7 Index Funds to Buy to Retire a Millionaire.6 days ago

Nasdaq

3 Reasons to Retain QIAGEN (QGEN) Stock in Your Portfolio.6 days ago

Nasdaq

Alcon (ALC) Q3 Earnings Surpass Estimates, Sales Guidance Cut.6 days ago

Nasdaq

PerkinElmer's (PKI) New Viral Vector Assays to Boost Workflows.6 days ago

The Motley Fool

3 Beaten-Down Growth Stocks That Billionaires Are Buying With Both Hands.6 days ago

SWAV Fair Value

Recent SEC filings of Shockwave Medical

View All Filings
Date Filed Form Type Document
Nov 28, 2022
4
Insider Trading
Nov 22, 2022
4
Insider Trading
Nov 18, 2022
4
Insider Trading
Nov 16, 2022
4
Insider Trading
Nov 07, 2022
10-Q
Quarterly Report
Nov 07, 2022
8-K
Current Report
Oct 27, 2022
4
Insider Trading
Oct 21, 2022
4
Insider Trading
Oct 21, 2022
4
Insider Trading
Oct 20, 2022
8-K
Current Report

Latest Insider Trading transactions for SWAV

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-25
Zacharias Isaac
ACQUIRED
26,840
6.71
4,000
President, CCO
2022-11-25
Zacharias Isaac
SOLD
-1,047,280
261.82
-4,000
President, CCO
2022-11-21
PUCKETT DAN
SOLD
-271,656
246.96
-1,100
Chief Financial Officer
2022-11-21
PUCKETT DAN
ACQUIRED
18,700
17
1,100
Chief Financial Officer
2022-11-17
WATKINS FRANK T
SOLD
-733,323
244.441
-3,000
-
2022-11-14
Godshall Douglas Evan
SOLD
-7,224,300
240.81
-30,000
President & CEO
2022-10-26
Zacharias Isaac
SOLD
-1,169,760
292.44
-4,000
President, CCO
2022-10-26
Zacharias Isaac
ACQUIRED
23,364.2
5.84105
4,000
President, CCO
2022-10-20
PUCKETT DAN
ACQUIRED
18,700
17
1,100
Chief Financial Officer
2022-10-20
PUCKETT DAN
SOLD
-295,185
268.35
-1,100
Chief Financial Officer

1–10 of 50

About Shockwave Medical

Douglas E. Godshall
www.shockwavemedical.com
660
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Income Statement

2022-09-30
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Product revenue$ 131,330$ 65,155$ 345,707$ 152,963
Cost of revenue:    
Cost of product revenue17,87410,94947,49428,775
Gross profit113,45654,206298,213124,188
Operating expenses:    
Research and development20,17713,73557,95635,827
Sales and marketing42,08228,393118,55878,098
General and administrative14,4349,26539,98825,117
Total operating expenses76,69351,393216,502139,042
Income (loss) from operations36,7632,81381,711(14,854)
Income (loss) from equity method investment97(342)(1,414)(5,865)
Interest expense(316)(165)(917)(795)
Other expense, net(1,423)(280)(3,206)(369)
Net income (loss) before taxes35,1212,02676,174(21,883)
Income tax expense118781,089195
Net income (loss)35,0031,94875,085(22,078)
Other comprehensive income (loss):    
Unrealized loss on available-for-sale securities(275)(17)(1,410)(16)
Total comprehensive income (loss)$ 34,728$ 1,931$ 73,675$ (22,094)
Net income (loss) per share    
Basic (USD per share)$ 0.97$ 0.06$ 2.10$ (0.63)
Diluted (USD per share)$ 0.92$ 0.05$ 1.99$ (0.63)
Denominator:    
Basic (in shares)36,003,93135,207,27635,807,26435,013,072
Diluted (in shares)37,948,04937,567,17637,813,10735,013,072
Type of Revenue [Extensible List]Product [Member]Product [Member]Product [Member]Product [Member]
Type of Cost, Good Or Service [Extensible List]Product [Member]Product [Member]Product [Member]Product [Member]

SWAV Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
[1]
CURRENT ASSETS:  
Cash and cash equivalents$ 127,779$ 89,209
Short-term investments122,888111,772
Accounts receivable, net64,22437,435
Inventory68,97442,978
Prepaid expenses and other current assets11,3934,508
Total current assets395,258285,902
Operating lease right-of-use assets33,10727,496
Property and equipment, net39,26524,361
Equity method investment4,5735,987
Other assets3,6061,936
TOTAL ASSETS475,809345,682
CURRENT LIABILITIES:  
Accounts payable3,4693,520
Term notes, current portion05,500
Accrued liabilities49,49240,870
Lease liability, current portion1,2601,738
Total current liabilities54,22151,628
Lease liability, noncurrent portion38,53228,321
Term notes, noncurrent portion14,85311,630
Related party contract liability, noncurrent portion12,27312,273
TOTAL LIABILITIES119,879103,852
STOCKHOLDERS’ EQUITY:  
Preferred stock00
Common stock3635
Additional paid-in capital535,230494,806
Accumulated other comprehensive loss(1,612)(202)
Accumulated deficit(177,724)(252,809)
TOTAL STOCKHOLDERS’ EQUITY355,930241,830
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 475,809$ 345,682
[1]The condensed consolidated balance sheet as of December 31, 2021 is derived from the audited consolidated financial statements as of that date.